Skip to main content

Cookies on Macro by Mark.We use essential cookies for sign-in, locale, and security. Optional analytics help us improve the product. Read our cookie policy.

Macro by MarkMacro by Mark
  • Home
  • News
  • Calendar
  • Indicators
  • Macro
  • About
Sign inSign up
Sign up
Macro by Mark

Global economic data, empirical models, and macro theory
All in one workspace

Public data from government agencies and multilateral statistical releases, anchored in official sources.

Product

  • Indicators
  • News
  • Calendar
  • Dashboard
  • Pricing

Macro

  • Models
  • Labs
  • Simulators
  • Concepts
  • Glossary
  • World

Account

  • Create account
  • Sign in
  • Help
  • Trust and security

Company

  • About
  • Docs
  • Contact
  • Editorial process
  • Feedback
  • Customer Support
Product+
  • Indicators
  • News
  • Calendar
  • Dashboard
  • Pricing
Macro+
  • Models
  • Labs
  • Simulators
  • Concepts
  • Glossary
  • World
Account+
  • Create account
  • Sign in
  • Help
  • Trust and security
Company+
  • About
  • Docs
  • Contact
  • Editorial process
  • Feedback
  • Customer Support
Privacy PolicyTerms of ServiceEthics and Compliance

© 2026 Mark Jayson Martinez Farol

Browse all concepts

Business & surveys · Canonical indicator

Corporate financials

business.corporate.financials

Company financial statements, profit/loss, and accounting statistics. Rows tagged fresh are chart-ready right now. The others remain in the catalog but have not been hydrated for live observation reads.

Quarterly Financial Report: U.S. Corporations: Petroleum and Coal Products: Trade Accounts and Trade Notes Payable was 105.2K on October 1, 2025, lower by 638 (-0.6%) from the prior observation. Charted from quarterly observations in mil. of $.

Chart-ready rows3,111
HydrationHydration backlog hidden
Top providersFRED (3,110), EUROSTAT (1)

By provider

FRED3,110 chart-readyEUROSTAT1 chart-ready

By country

Global3,045US65Finland1

Series

Showing 2,001-2,050 of 3,111

50 chart-ready rows per page. Hydration-backlog and unavailable rows are hidden unless you open audit mode.

Live chart loads from cacheHydration pending scheduled hydration is pendingShow full catalog audit

Unknown

  • Quarterly Financial Report: U.S. Corporations: Petroleum and Coal Products: Trade Accounts and Trade Notes PayableFRED· quarterly
· Mil. of $
Live
  • Quarterly Financial Report: U.S. Corporations: Petroleum and Coal Products: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts)FRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Accumulated Depreciation, Depletion, and AmortizationFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Current AssetsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Current LiabilitiesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Noncurrent AssetsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Noncurrent LiabilitiesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Nonoperating Income (Expense)FRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Operating Costs and ExpensesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Capital Stock and Other Capital (Less Treasury Stock)FRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This QuarterFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash and Demand Deposits in the U.S.FRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Current Portion of Long-Term Debt, Due in 1 Year or Less: Loans from BanksFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Current Portion of Long-Term Debt, Due in 1 Year or Less: Other Long-Term LoansFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Depreciation, Depletion, and Amortization of Property, Plant, and EquipmentFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) After Income TaxesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) Before Income TaxesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) from OperationsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income Taxes Accrued, Prior and Current Years, Net of PaymentsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest ExpenseFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: InventoriesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Land and Mineral RightsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Long-Term Debt, Due in More Than 1 Year: Loans from BanksFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Long-Term Debt, Due in More Than 1 Year: Other Long-Term LoansFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Income Retained in BusinessFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Property, Plant, and EquipmentFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating RevenuesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Working CapitalFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Other Direct Credits (Charges) to Retained Earnings (Net)FRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Other Short-Term Financial InvestmentsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Property, Plant, and EquipmentFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Provision for Current and Deferred Domestic Income TaxesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Retained EarningsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Retained Earnings at Beginning of QuarterFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Retained Earnings at End of QuarterFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from BanksFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Short-Term Debt, Original Maturity of 1 Year or Less: Other Short-Term Loans, Including Commercial PaperFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Stockholders' EquityFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Time Deposits in the U.S., Including Negotiable Certificates of DepositFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total AssetsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Cash on Hand and in U.S. BanksFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Cash, U.S. Government and Other SecuritiesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Current AssetsFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Current LiabilitiesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total LiabilitiesFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities and Stockholders' EquityFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Trade Accounts and Trade Notes PayableFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts)FRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: Accumulated Depreciation, Depletion, and AmortizationFRED· quarterly· Mil. of $Live
  • Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: All Other Current AssetsFRED· quarterly· Mil. of $Live
    • PreviousPage 41 of 63Next